As the year closes out and we put our deals to bed, now is a good time to reflect on the status of biotech funding here in Boston. We all know that Boston has the edge; how can we keep it that way?

We are bringing together some of Boston\’s most successful CEOs and company founders for an evening of candid conversation. These “been there done that” industry veterans will share insights into where they have secured funding in the past, what to avoid when attempting to raise capital, and what they have to say about current finance trends. Their track records in building groundbreaking and successful businesses speak for themselves – so join us for what will be not only an informative and entertaining evening, but a great chance to close out the year and spread a little holiday cheer.

Our panel discussions are candid, interactive and informal. We hope you walk away with the real story behind how things work so you can make it happen for yourself. In addition to this panel discussion, there will also be an opportunity to donate items to Rosie\’s Place, a local charity.

Agenda:
3:00pm | Registration & Networking
3:30pm | Introductions
3:35pm | Panel Presentation
5:00pm | Networking Reception
6:30pm | Close

Panelists:
Chip Clark | CEO, Genocea read bio»
Amy Shulman | CEO, Arsia Therapeutics read bio»
Steven Tregay | CEO, Forma Therapeutics read bio»
Daphne Zohar | CEO, Puretech read bio»
[moderator] Marian Nakada | Vice President, Venture Investments, Johnson & Johnson Development Corporation  read bio»

Fees:
$30 | General Public
$15 | Student/Academic
$40 | General Public Onsite

Venue:
Microsoft
255 Main St.
4th Floor Multi-Purpose Room
Cambridge, MA 02142